Oxycodone Lp Sandoz (Oxycodone Hydrochloride)

Oxycodone Lp Sandoz is an opioid analgesic that acts on the central nervous system to relieve pain.

• Chronic cancer‑related pain: provides long‑lasting relief for patients with persistent tumor‑associated pain.
• Post‑operative pain: manages moderate to severe pain after major surgical procedures.
• Severe traumatic injury pain: controls intense pain following serious injuries such as fractures or burns.
• Chronic non‑cancer pain: offers sustained analgesia for conditions like severe osteoarthritis when other treatments have failed.

• Oxycodone binds to μ‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. This receptor activation also decreases the release of neurotransmitters involved in pain signaling, producing an overall analgesic effect.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: mild to moderate queasiness.
• Drowsiness: increased sleepiness or sedation.
• Dizziness: light‑headed feeling, especially when standing.
• Dry mouth: decreased salivation.
• Sweating: excess perspiration without exertion.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure.
• Seizures: convulsive episodes, particularly with overdose.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Dependence and addiction: potential for physical and psychological dependence with prolonged use.
• Adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Oxycodone Lp Sandoz, clinicians should assess patient history and monitor for adverse reactions.

• Assess risk of respiratory depression: evaluate respiratory function before initiating therapy.
• Evaluate for opioid tolerance: adjust dose only for patients with established opioid tolerance.
• Monitor for signs of dependence: watch for cravings, withdrawal symptoms, or misuse behaviors.
• Use caution in renal or hepatic impairment: dose adjustments may be required.
• Avoid concurrent CNS depressants: limit use with alcohol, benzodiazepines, or other sedatives.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone Lp Sandoz may interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase oxycodone plasma levels and risk of respiratory depression.
• CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): additive sedative effects and heightened respiratory risk.
• MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may reduce conversion of oxycodone to its active metabolite, affecting analgesia.
• Anticholinergic agents: may worsen constipation.
• Diuretics: can increase risk of orthostatic hypotension.
• Antihistamines: may intensify drowsiness.
• Herbal supplements: St [       ]